ML-9

ML-9 is a myosin light chain kinase (MLCK) inhibitor. It enhances the anticancer activity of docetaxel and has potential application as an adjuvant to existing anticancer chemotherapy. It is used as an attractive tool for targeting autophagy in cancer therapy through dual inhibition of both the Akt pathway and the autophagy.
Supplier BOC Sciences
Product # 110448-31-2
Pricing Inquire
Cas 110448-31-2
Molecular Weight 324.82
Molecular Formula C15H17ClN2O2S
Canonical SMILES C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl
Feedback